Insights

Understanding blockchain – a practical guide for life sciences companies

Within the life science industry, uptake of blockchain is in the early stages, but with investment levels in

Understanding blockchain – a practical guide for life sciences companies

https://pharmaphorum.com/digital/insights-digital/understanding-blockchain-life-sciences/

How pharma can boost engagement by embracing support networks

Connecting with patients has become a central plank in the pharma marketing playbook, but should companies be looking

How pharma can boost engagement by embracing support networks

https://pharmaphorum.com/patients/insights-patients/how-pharma-can-boost-engagement-by-embracing-support-networks/

Patient centricity: Identifying how Boehringer Ingelheim UK can be better

Boehringer Ingelheim UK provides an update on its patient centricity initiative ahead of a new white paper later this year.

Patient centricity: Identifying how Boehringer Ingelheim UK can be better

https://pharmaphorum.com/debates-insight-patients/patient-centricity-identifying-boehringer-ingelheim-uk-can-better/

From ideals to execution: the reality of patient-centricity in 2016 and what’s next for pharma

‘Patient-centricity’ is one of the buzzwords of the life sciences industry. It demonstrates a shift in the way

From ideals to execution: the reality of patient-centricity in 2016 and what’s next for pharma

https://pharmaphorum.com/whitepapers/ideals-execution-reality-patient-centricity-2016-whats-next-pharma/

An integrated digital ecosystem to support patient outcomes, health-system sustainability, and return on investment

Demand for improved pharmaceutical care that enhances the patient experience is ever increasing, and meanwhile outcomes-based medicine

An integrated digital ecosystem to support patient outcomes, health-system sustainability, and return on investment

https://pharmaphorum.com/whitepapers/an-integrated-digital-ecosystem-to-support-patient-outcomes-health-system-sustainability-and-return-on-investment/

Patient centricity: How does Boehringer Ingelheim UK measure up?

Patient centricity is a subject that is massively talked about but few can ‘walk the talk’. Fewer still can demonstrate what

Patient centricity: How does Boehringer Ingelheim UK measure up?

https://pharmaphorum.com/whitepapers/patient-centricity-how-does-boehringer-ingelheim-uk-measure-up/

Patient centricity: What it means and why it’s important to have patients at the centre of our thinking

Having clear parameters of patient‑centricity that can be measured year-on-year enables Boehringer Ingelheim UK to know if it

Patient centricity: What it means and why it’s important to have patients at the centre of our thinking

https://pharmaphorum.com/whitepapers/patient-centricity-what-it-means-and-why-it-s-important-to-have-patients-at-the-centre-of-our-thinking/

Improved health and wellbeing in COPD

Chronic obstructive pulmonary disease (COPD) is a progressive and debilitating disorder, which, as it progresses, places a significant

Improved health and wellbeing in COPD

https://pharmaphorum.com/whitepapers/improved-health-and-wellbeing-in-copd/

Modelling patient behaviour to improve self-management in diabetes

An understanding of health psychology is essential to helping patients adhere to their medication and lifestyle regimens. This

Modelling patient behaviour to improve self-management in diabetes

https://pharmaphorum.com/whitepapers/modelling-patient-behaviour-to-improve-self-management-in-diabetes/

1 2 3

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com

Search

Advanced Search

Trending

Insights